- Nachrichtendetail
-
27.02.2024 13:04:30 - dpa-AFX: *LIGAND PHARMA Q4 CORE ADJ. NET INCOME RISES TO $18.6 MLN OR $1.05/SHR FROM $13.0 MLN OR $0.75/SHR LAST YEAR
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Ligand Pharmaceuticals | A1C9RN | NASDAQ | 109,310 | 30.07.24 19:52:03 | +0,560 | +0,51% | 108,830 | 109,880 | 109,800 | 108,750 |
